Susan X Zhao, MD
Cardiovascular Disease (Cardiology) · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 18
- 3 carriers
- Office
- 1
- Since medical school
- 21 years
- Harvard Medical School, 2005
Offices
1 location · County of Santa Clara · 1,000 clinicians in this group
Hospitals listed: Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
18 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Zhao’s office at (408) 885-5000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
18 of 18 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$54,477
Medicare paid this office $54,477 for 595 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 263 | $16,381 | $61 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 63 | $11,723 | $104 |
| Return visit (30+ min) | 79 | $8,235 | $81 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 51 | $7,908 | $149 |
| Short return visit (20+ min) | 47 | $2,448 | $50 |
See all 8 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 263 | $16,381 | $61 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 63 | $11,723 | $104 |
| Return visit (30+ min) | 79 | $8,235 | $81 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 51 | $7,908 | $149 |
| Short return visit (20+ min) | 47 | $2,448 | $50 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 161 | $1,289 | $7 |
| Ultrasound of heart, follow-up | 12 | $291 | $22 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 14 | $65 | $5 |
Who their Medicare patients are
595 Original Medicare patients in 2024. Average age 75 · Under 65 11% · 85 and older 22% · Women 46% · Also on Medicaid 75% · Health risk score 2.70. Sicker patients than 9 in 10 peers; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Diabetes 57% · Heart failure 52% · Coronary heart disease 51% · Chronic kidney disease 45% · Atrial fibrillation 42% · Depression 24% · Stroke 24% · COPD 23% · Dementia 23% · Cancer 15%.
The office billed $574,302, Medicare allowed $71,496 and paid $54,477; for 872 services of 26 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 595 | 872 | 75 | 2.70 | $574,302 | $54,477 |
| 2023 | 547 | 772 | 74 | 2.49 | $450,504 | $43,256 |
| 2022 | 653 | 886 | 73 | 2.28 | $470,083 | $48,588 |
| 2021 | 806 | 1,180 | 73 | 2.35 | $490,192 | $54,422 |
| 2020 | 877 | 1,342 | 72 | 2.52 | $557,626 | $59,859 |
| 2019 | 1,038 | 1,647 | 71 | 2.38 | $778,875 | $65,867 |
| 2018 | 1,004 | 1,506 | 71 | 2.34 | $850,587 | $57,601 |
| 2017 | 964 | 1,427 | 70 | 2.35 | $847,623 | $48,238 |
| 2016 | 809 | 1,268 | 70 | 2.30 | $576,003 | $52,988 |
| 2015 | 527 | 759 | 70 | 2.19 | $296,877 | $38,060 |
| 2014 | 656 | 995 | 70 | 1.78 | $334,495 | $46,056 |
| 2013 | 521 | 732 | 70 | 1.91 | $227,724 | $36,847 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 9 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 243 | $13,888 | $56 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 44 | $7,205 | $164 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 37 | $6,225 | $109 |
| Short return visit (20+ min) | 100 | $5,353 | $49 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 41 | $4,834 | $74 |
| Return visit (30+ min) | 19 | $1,626 | $81 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 12 | $1,435 | $120 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 120 | $1,040 | $7 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 14 | $75 | $5 |
2022: 9 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 267 | $16,148 | $59 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 42 | $9,351 | $217 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 48 | $9,157 | $112 |
| Short return visit (20+ min) | 72 | $4,883 | $55 |
| Return visit (30+ min) | 26 | $2,318 | $86 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 212 | $1,580 | $7 |
| Telephone medical discussion with physician, 11-20 minutes | 13 | $643 | $46 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 22 | $609 | $25 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 33 | $161 | $5 |
2021: 11 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 292 | $18,824 | $62 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 51 | $10,943 | $215 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 41 | $7,921 | $115 |
| Return visit (30+ min) | 35 | $3,623 | $91 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 377 | $3,369 | $7 |
| Short return visit (20+ min) | 53 | $2,926 | $53 |
| Telephone medical discussion with physician, 21-30 minutes | 17 | $1,394 | $82 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 33 | $768 | $23 |
| Telephone medical discussion with physician, 5-10 minutes | 15 | $439 | $29 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 44 | $278 | $6 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 11 | $231 | $19 |
2020: 15 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 329 | $22,800 | $65 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 48 | $10,973 | $111 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 48 | $10,141 | $207 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 386 | $3,562 | $7 |
| Telephone medical discussion with physician, 11-20 minutes | 56 | $2,453 | $42 |
| Return visit (30+ min) | 28 | $2,192 | $59 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $1,319 | $78 |
| Short return visit (20+ min) | 25 | $1,053 | $42 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 26 | $646 | $24 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 29 | $501 | $17 |
| Telephone medical discussion with physician, 5-10 minutes | 18 | $405 | $20 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 29 | $336 | $12 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 50 | $205 | $4 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 12 | $126 | $10 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 12 | $85 | $7 |
2019: 16 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 377 | $24,975 | $64 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 55 | $10,610 | $94 |
| Return visit (30+ min) | 86 | $7,272 | $62 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 32 | $5,797 | $176 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 447 | $3,805 | $7 |
| Short return visit (20+ min) | 53 | $2,086 | $39 |
| Ultrasound of heart with probe in esophagus, with report | 11 | $1,108 | $101 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 45 | $1,092 | $24 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 46 | $776 | $17 |
| New patient visit (30+ min) | 19 | $757 | $40 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 92 | $527 | $6 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 46 | $523 | $11 |
| Ultrasound of heart, follow-up | 17 | $451 | $24 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 16 | $246 | $15 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 16 | $165 | $10 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 11 | $74 | $7 |
2018: 17 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 370 | $22,522 | $60 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 47 | $8,613 | $93 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 37 | $6,794 | $179 |
| Return visit (30+ min) | 73 | $5,304 | $60 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 450 | $3,779 | $7 |
| Short return visit (20+ min) | 43 | $1,651 | $38 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $1,307 | $65 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 55 | $1,045 | $19 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 54 | $687 | $13 |
| New patient visit (30+ min) | 12 | $624 | $52 |
| Ultrasound of heart, follow-up | 25 | $583 | $22 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 11 | $270 | $25 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 15 | $241 | $16 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 41 | $215 | $5 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 15 | $162 | $11 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 14 | $99 | $7 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 21 | $61 | $3 |
2017: 18 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 387 | $20,694 | $52 |
| Return visit (30+ min) | 44 | $3,678 | $65 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 24 | $3,634 | $151 |
| Short return visit (20+ min) | 73 | $3,274 | $39 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 361 | $3,027 | $7 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 17 | $2,246 | $90 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 17 | $2,075 | $122 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 23 | $1,827 | $59 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 64 | $1,244 | $19 |
| Ultrasound of heart | 31 | $1,107 | $36 |
| Ultrasound of heart, follow-up | 38 | $954 | $23 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 64 | $835 | $13 |
| New patient visit (30+ min) | 12 | $747 | $62 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 41 | $213 | $5 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 13 | $195 | $15 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 20 | $139 | $7 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 13 | $136 | $10 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 33 | $102 | $3 |
2016: 13 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 369 | $21,144 | $55 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 34 | $5,909 | $174 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 21 | $3,518 | $93 |
| Return visit (30+ min) | 44 | $3,432 | $59 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 31 | $2,894 | $64 |
| Short return visit (20+ min) | 68 | $2,367 | $32 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 242 | $2,148 | $7 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 17 | $2,065 | $121 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 102 | $1,822 | $18 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 109 | $1,254 | $12 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 12 | $709 | $59 |
| Ultrasound of heart, follow-up | 21 | $558 | $23 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 12 | $83 | $7 |
2015: 8 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 310 | $17,210 | $54 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 38 | $4,522 | $113 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 35 | $3,187 | $61 |
| Short return visit (20+ min) | 65 | $2,943 | $38 |
| Return visit (30+ min) | 37 | $2,653 | $60 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 67 | $1,095 | $16 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 84 | $883 | $11 |
| Ultrasound of heart, follow-up | 13 | $292 | $22 |
2014: 9 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 364 | $19,640 | $53 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 42 | $5,112 | $122 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 38 | $4,612 | $63 |
| Return visit (30+ min) | 49 | $3,806 | $54 |
| Short return visit (20+ min) | 78 | $3,795 | $35 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 106 | $1,812 | $17 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 138 | $1,585 | $11 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 15 | $900 | $60 |
| Ultrasound of heart, follow-up | 22 | $530 | $23 |
2013: 10 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 240 | $13,103 | $54 |
| Return visit (30+ min) | 65 | $5,833 | $61 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 30 | $3,449 | $115 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 27 | $2,613 | $62 |
| Ultrasound of heart | 75 | $2,611 | $35 |
| New patient visit (45+ min) | 17 | $1,585 | $93 |
| Short return visit (20+ min) | 35 | $1,415 | $38 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 88 | $1,008 | $11 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 41 | $709 | $17 |
| Ultrasound of heart, follow-up | 14 | $333 | $22 |
Medicaid work
$15,652 in 2024
Medicaid paid $15,652 for 2,021 billed services this clinician did in 2024, up to 96 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 641 | $9,184 |
| Return visit (30+ min) | 164 | $1,991 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 467 | $1,895 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 101 | $1,877 |
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 13 | $330 |
| Short return visit (20+ min) | 19 | $221 |
| IP/OBS CONSLTJ NEW/EST PT HIGH MDM 80 MINUTES | 12 | $155 |
| Pain severity quantified; no pain present (COA) (ONC) | 19 | $0 |
| Medication list documented in medical record (COA) | 233 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 131 | $0 |
| Most recent systolic blood pressure greater than or equal to 140 mm Hg (HTN, CKD, CAD) (DM) | 12 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 209 | $0 |
| 2024 | 2,021 | 12 | 96 | $15,652 |
| 2023 | 1,658 | 11 | 122 | $14,945 |
| 2022 | 1,522 | 7 | 102 | $16,443 |
| 2021 | 2,282 | 7 | 103 | $24,961 |
| 2020 | 1,988 | 6 | 107 | $21,039 |
| 2019 | 2,593 | 7 | 122 | $21,291 |
| 2018 | 2,703 | 9 | 129 | $24,120 |
See the largest Medicaid services in earlier years
2023
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 704 | $9,400 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 83 | $1,713 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 493 | $1,587 |
| Short return visit (20+ min) | 189 | $1,165 |
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 32 | $556 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 40 | $315 |
| Return visit (30+ min) | 15 | $209 |
| Most recent hemoglobin A1c (HbA1c) level less than 7.0% (DM) | 16 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 25 | $0 |
| Most recent systolic blood pressure greater than or equal to 140 mm Hg (HTN, CKD, CAD) (DM) | 12 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 49 | $0 |
2022
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 636 | $11,738 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 646 | $2,629 |
| Short return visit (20+ min) | 147 | $964 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 21 | $427 |
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 40 | $317 |
| Return visit (30+ min) | 18 | $302 |
| External electrocardiographic recording for more than 7 days up to 15 days by continuous rhythm recording and storage; review and interpretation | 14 | $66 |
2021
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 783 | $16,825 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 1,194 | $4,654 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 55 | $1,561 |
| Short return visit (20+ min) | 121 | $820 |
| Return visit (30+ min) | 84 | $809 |
| External electrocardiographic recording for more than 7 days up to 15 days by continuous rhythm recording and storage; review and interpretation | 33 | $201 |
| External electrocardiographic recording for more than 7 days up to 15 days by continuous rhythm recording and storage; recording (includes connection and initial recording) | 12 | $92 |
2020
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 766 | $15,524 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 1,086 | $4,797 |
| CARDIOVASCULAR STRESS TEST | 53 | $230 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 14 | $215 |
| CARDIOVASCULAR STRESS TEST | 53 | $152 |
| Return visit (30+ min) | 16 | $120 |
2019
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 806 | $14,212 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 1,194 | $3,847 |
| Return visit (30+ min) | 211 | $915 |
| CARDIOVASCULAR STRESS TEST | 128 | $736 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 86 | $594 |
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 41 | $513 |
| CARDIOVASCULAR STRESS TEST | 127 | $474 |
2018
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 800 | $15,697 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 1,326 | $4,796 |
| Return visit (30+ min) | 191 | $1,159 |
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 40 | $791 |
| CARDIOVASCULAR STRESS TEST | 151 | $627 |
| CARDIOVASCULAR STRESS TEST | 150 | $426 |
| IP/OBS CONSLTJ NEW/EST PT HIGH MDM 80 MINUTES | 13 | $302 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 18 | $181 |
| ECHO TRANSTHORC R-T 2D W/WO M-MODE REC F-UP/LMTD | 14 | $142 |
Drugs they prescribed that Part D paid
$465,055
Pharmacies billed $465,055 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,556) in 2024. At or below the middle of the specialty; the typical cardiology clinician is at 0%.
1,115 generic and 441 brand-name prescriptions · $465,055 in drug cost · 12 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 157 | $193,704 | $1,234 |
| Jardiance | 122 | $134,093 | $1,099 |
| Xarelto | 44 | $48,978 | $1,113 |
| Entresto | 17 | $23,997 | $1,412 |
| Multaq | 12 | $15,701 | $1,308 |
See all 29 drugs
| Eliquis | 157 | $193,704 | $1,234 |
| Jardiance | 122 | $134,093 | $1,099 |
| Xarelto | 44 | $48,978 | $1,113 |
| Entresto | 17 | $23,997 | $1,412 |
| Multaq | 12 | $15,701 | $1,308 |
| Isosorbide Dinitrate | 42 | $2,459 | $59 |
| Bumetanide | 39 | $2,008 | $51 |
| Ranolazine Er | 27 | $1,392 | $52 |
| Metoprolol | 94 | $1,260 | $13 |
| Furosemide | 134 | $781 | $6 |
| Amiodarone | 40 | $708 | $18 |
| Sildenafil Citrate | 14 | $665 | $48 |
| Atorvastatin | 81 | $633 | $8 |
| Clopidogrel | 72 | $610 | $8 |
| Propafenone | 14 | $422 | $30 |
| Carvedilol | 76 | $391 | $5 |
| Rosuvastatin | 25 | $370 | $15 |
| Flecainide Acetate | 22 | $369 | $17 |
| Hydralazine | 27 | $359 | $13 |
| Potassium Chloride | 14 | $355 | $25 |
| Nitroglycerin | 47 | $335 | $7 |
| Losartan | 57 | $280 | $5 |
| Lisinopril | 33 | $257 | $8 |
| Isosorbide Mononitrate Er | 17 | $229 | $13 |
| Metoprolol | 45 | $176 | $4 |
| Spironolactone | 33 | $164 | $5 |
| Amlodipine Besylate | 58 | $159 | $3 |
| Pantoprazole | 18 | $141 | $8 |
| Hydrochlorothiazide | 16 | $80 | $5 |
Year by year
| 2024 | 1,556 | 252 | 0% (0) | 28% | $465,055 |
| 2023 | 1,208 | 216 | 0% (0) | 26% | $369,198 |
| 2022 | 1,182 | 181 | 0% (0) | 23% | $292,777 |
| 2021 | 931 | 164 | 0% (0) | 26% | $188,808 |
| 2020 | 887 | 162 | 0% (0) | 28% | $152,075 |
| 2019 | 869 | 181 | 0% (0) | 30% | $134,651 |
| 2018 | 846 | 152 | 0% (0) | 28% | $107,930 |
| 2017 | 740 | 133 | 0% (0) | 22% | $46,437 |
| 2016 | 700 | 116 | 0% (0) | None | $34,504 |
| 2015 | 530 | 104 | 0% (0) | 26% | $26,496 |
| 2014 | 522 | 101 | 0% (0) | None | $18,724 |
| 2013 | 435 | 88 | None | None | $15,549 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 27 drugs
| Eliquis | 140 | $175,247 | $1,252 |
| Jardiance | 54 | $65,417 | $1,211 |
| Xarelto | 42 | $49,862 | $1,187 |
| Repatha Sureclick | 13 | $17,854 | $1,373 |
| Sildenafil Citrate | 21 | $7,286 | $347 |
| Ranolazine Er | 25 | $3,463 | $139 |
| Amiodarone | 38 | $3,019 | $79 |
| Isosorbide Dinitrate | 24 | $2,977 | $124 |
| Bumetanide | 40 | $2,946 | $74 |
| Atorvastatin | 75 | $2,514 | $34 |
| Furosemide | 124 | $1,587 | $13 |
| Clopidogrel | 67 | $1,534 | $23 |
| Metoprolol | 51 | $1,087 | $21 |
| Potassium Chloride | 15 | $1,011 | $67 |
| Amlodipine Besylate | 59 | $939 | $16 |
| Flecainide Acetate | 24 | $734 | $31 |
| Carvedilol | 42 | $694 | $17 |
| Losartan | 30 | $689 | $23 |
| Rosuvastatin | 21 | $545 | $26 |
| Hydralazine | 28 | $545 | $19 |
| Isosorbide Mononitrate Er | 15 | $525 | $35 |
| Nitroglycerin | 38 | $525 | $14 |
| Spironolactone | 24 | $509 | $21 |
| Lisinopril | 16 | $379 | $24 |
| Digoxin | 13 | $315 | $24 |
| Metoprolol | 28 | $310 | $11 |
| Hydrochlorothiazide | 14 | $222 | $16 |
2022: 28 drugs
| Eliquis | 123 | $121,320 | $986 |
| Xarelto | 55 | $56,274 | $1,023 |
| Jardiance | 26 | $34,828 | $1,340 |
| Multaq | 17 | $25,527 | $1,502 |
| Repatha Sureclick | 12 | $9,500 | $792 |
| Bumetanide | 59 | $8,855 | $150 |
| Sildenafil Citrate | 26 | $4,843 | $186 |
| Ranolazine Er | 20 | $4,543 | $227 |
| Isosorbide Dinitrate | 27 | $3,283 | $122 |
| Amiodarone | 28 | $2,385 | $85 |
| Atorvastatin | 107 | $1,723 | $16 |
| Metoprolol | 71 | $1,383 | $19 |
| Furosemide | 104 | $1,312 | $13 |
| Isosorbide Mononitrate Er | 47 | $980 | $21 |
| Rosuvastatin | 20 | $934 | $47 |
| Carvedilol | 52 | $858 | $17 |
| Clopidogrel | 57 | $800 | $14 |
| Clonidine | 13 | $769 | $59 |
| Digoxin | 16 | $727 | $45 |
| Diltiazem 24hr Er (Cd) | 14 | $660 | $47 |
| Amlodipine Besylate | 57 | $621 | $11 |
| Flecainide Acetate | 17 | $614 | $36 |
| Nitroglycerin | 22 | $381 | $17 |
| Metoprolol | 25 | $299 | $12 |
| Hydralazine | 12 | $225 | $19 |
| Losartan | 17 | $201 | $12 |
| Lisinopril | 23 | $89 | $4 |
| Hydrochlorothiazide | 12 | $82 | $7 |
2021: 23 drugs
| Eliquis | 64 | $59,904 | $936 |
| Xarelto | 52 | $59,066 | $1,136 |
| Multaq | 16 | $24,858 | $1,554 |
| Bumetanide | 46 | $5,852 | $127 |
| Ranolazine Er | 19 | $2,427 | $128 |
| Amiodarone | 37 | $2,009 | $54 |
| Isosorbide Dinitrate | 11 | $1,615 | $147 |
| Atorvastatin | 106 | $1,255 | $12 |
| Furosemide | 81 | $823 | $10 |
| Metoprolol | 52 | $767 | $15 |
| Flecainide Acetate | 24 | $762 | $32 |
| Digoxin | 19 | $682 | $36 |
| Clopidogrel | 50 | $667 | $13 |
| Nitroglycerin | 31 | $582 | $19 |
| Isosorbide Mononitrate Er | 29 | $505 | $17 |
| Carvedilol | 43 | $475 | $11 |
| Amlodipine Besylate | 49 | $452 | $9 |
| Rosuvastatin | 13 | $384 | $30 |
| Hydralazine | 30 | $303 | $10 |
| Losartan | 14 | $141 | $10 |
| Metoprolol | 22 | $131 | $6 |
| Simvastatin | 13 | $61 | $5 |
| Hydrochlorothiazide | 12 | $44 | $4 |
2020: 22 drugs
| Xarelto | 57 | $54,876 | $963 |
| Eliquis | 54 | $42,354 | $784 |
| Multaq | 19 | $25,841 | $1,360 |
| Ranolazine Er | 21 | $4,463 | $213 |
| Bumetanide | 28 | $4,190 | $150 |
| Atorvastatin | 86 | $1,211 | $14 |
| Furosemide | 69 | $956 | $14 |
| Amiodarone | 38 | $883 | $23 |
| Flecainide Acetate | 22 | $841 | $38 |
| Clopidogrel | 60 | $710 | $12 |
| Carvedilol | 45 | $568 | $13 |
| Nitroglycerin | 30 | $558 | $19 |
| Metoprolol | 25 | $552 | $22 |
| Isosorbide Mononitrate Er | 31 | $538 | $17 |
| Digoxin | 14 | $448 | $32 |
| Amlodipine Besylate | 68 | $398 | $6 |
| Hydralazine | 36 | $369 | $10 |
| Sildenafil Citrate | 11 | $349 | $32 |
| Nifedipine Er | 12 | $344 | $29 |
| Losartan | 17 | $263 | $15 |
| Metoprolol | 28 | $220 | $8 |
| Simvastatin | 13 | $78 | $6 |
2019: 22 drugs
| Xarelto | 62 | $53,971 | $870 |
| Eliquis | 46 | $31,018 | $674 |
| Ranexa | 16 | $16,783 | $1,049 |
| Isosorbide Dinitrate | 17 | $2,128 | $125 |
| Amiodarone | 31 | $1,845 | $60 |
| Bumetanide | 12 | $1,436 | $120 |
| Atorvastatin | 82 | $1,181 | $14 |
| Furosemide | 87 | $1,167 | $13 |
| Metoprolol | 40 | $1,007 | $25 |
| Flecainide Acetate | 21 | $937 | $45 |
| Sildenafil Citrate | 25 | $697 | $28 |
| Isosorbide Mononitrate Er | 27 | $647 | $24 |
| Amlodipine Besylate | 82 | $615 | $7 |
| Nifedipine Er | 20 | $606 | $30 |
| Clopidogrel | 40 | $605 | $15 |
| Carvedilol | 43 | $533 | $12 |
| Hydralazine | 40 | $529 | $13 |
| Potassium Chloride | 11 | $427 | $39 |
| Nitroglycerin | 24 | $362 | $15 |
| Metoprolol | 27 | $226 | $8 |
| Losartan | 14 | $170 | $12 |
| Simvastatin | 11 | $79 | $7 |
2018: 22 drugs
| Xarelto | 70 | $44,090 | $630 |
| Ranexa | 24 | $21,856 | $911 |
| Multaq | 12 | $15,247 | $1,271 |
| Isosorbide Dinitrate | 11 | $2,180 | $198 |
| Flecainide Acetate | 26 | $1,393 | $54 |
| Atorvastatin | 74 | $1,081 | $15 |
| Furosemide | 91 | $976 | $11 |
| Digox | 16 | $970 | $61 |
| Isosorbide Mononitrate Er | 37 | $888 | $24 |
| Clopidogrel | 45 | $816 | $18 |
| Metoprolol | 33 | $718 | $22 |
| Nifedipine Er | 19 | $692 | $36 |
| Potassium Chloride | 20 | $560 | $28 |
| Amiodarone | 21 | $514 | $24 |
| Carvedilol | 41 | $424 | $10 |
| Sildenafil | 14 | $373 | $27 |
| Amlodipine Besylate | 56 | $366 | $7 |
| Metoprolol | 30 | $308 | $10 |
| Hydralazine | 23 | $302 | $13 |
| Nitroglycerin | 11 | $192 | $17 |
| Losartan | 22 | $177 | $8 |
| Lisinopril | 11 | $59 | $5 |
2017: 22 drugs
| Xarelto | 39 | $22,267 | $571 |
| Isosorbide Dinitrate | 19 | $2,648 | $139 |
| Sildenafil | 23 | $1,342 | $58 |
| Digox | 21 | $1,241 | $59 |
| Bumetanide | 14 | $1,107 | $79 |
| Atorvastatin | 46 | $839 | $18 |
| Furosemide | 87 | $817 | $9 |
| Metoprolol | 35 | $817 | $23 |
| Nifedipine Er | 18 | $718 | $40 |
| Clopidogrel | 38 | $560 | $15 |
| Isosorbide Mononitrate Er | 34 | $549 | $16 |
| Carvedilol | 48 | $509 | $11 |
| Potassium Chloride | 14 | $415 | $30 |
| Losartan | 35 | $411 | $12 |
| Amlodipine Besylate | 44 | $355 | $8 |
| Metoprolol | 29 | $309 | $11 |
| Fosinopril | 22 | $257 | $12 |
| Amiodarone | 15 | $227 | $15 |
| Benazepril | 16 | $161 | $10 |
| Lisinopril | 16 | $97 | $6 |
| Spironolactone | 14 | $56 | $4 |
| Simvastatin | 11 | $45 | $4 |
2016: 19 drugs
| Xarelto | 21 | $11,426 | $544 |
| Isosorbide Dinitrate | 39 | $3,015 | $77 |
| Sildenafil | 19 | $1,235 | $65 |
| Metoprolol | 47 | $1,231 | $26 |
| Nifedipine Er | 17 | $926 | $54 |
| Carvedilol | 59 | $454 | $8 |
| Amlodipine Besylate | 57 | $448 | $8 |
| Isosorbide Mononitrate Er | 25 | $434 | $17 |
| Atorvastatin | 20 | $418 | $21 |
| Clopidogrel | 25 | $346 | $14 |
| Furosemide | 71 | $343 | $5 |
| Nitrostat | 14 | $326 | $23 |
| Metoprolol | 34 | $255 | $8 |
| Fosinopril | 27 | $237 | $9 |
| Amiodarone | 21 | $236 | $11 |
| Losartan | 23 | $185 | $8 |
| Levothyroxine | 11 | $178 | $16 |
| Lisinopril | 11 | $112 | $10 |
| Simvastatin | 12 | $50 | $4 |
2015: 17 drugs
| Xarelto | 12 | $4,672 | $389 |
| Isosorbide Dinitrate | 35 | $3,298 | $94 |
| Ranexa | 12 | $3,273 | $273 |
| Amiodarone | 12 | $1,765 | $147 |
| Cardura Xl | 12 | $1,154 | $96 |
| Metoprolol | 36 | $1,104 | $31 |
| Potassium Chloride | 17 | $801 | $47 |
| Atorvastatin | 21 | $566 | $27 |
| Clopidogrel | 34 | $348 | $10 |
| Amlodipine Besylate | 55 | $321 | $6 |
| Nifedipine Er | 12 | $313 | $26 |
| Metoprolol | 42 | $250 | $6 |
| Carvedilol | 21 | $241 | $11 |
| Nitrostat | 14 | $240 | $17 |
| Furosemide | 38 | $237 | $6 |
| Losartan | 16 | $111 | $7 |
| Simvastatin | 16 | $107 | $7 |
2014: 16 drugs
| Isosorbide Dinitrate | 31 | $3,623 | $117 |
| Metoprolol | 34 | $1,312 | $39 |
| Clopidogrel | 20 | $657 | $33 |
| Atorvastatin | 28 | $610 | $22 |
| Pravastatin | 16 | $568 | $36 |
| Carvedilol | 29 | $449 | $15 |
| Simvastatin | 34 | $387 | $11 |
| Fosinopril | 16 | $353 | $22 |
| Amlodipine Besylate | 43 | $302 | $7 |
| Losartan | 24 | $295 | $12 |
| Furosemide | 47 | $223 | $5 |
| Nitrostat | 12 | $204 | $17 |
| Metoprolol | 26 | $195 | $7 |
| Amiodarone | 15 | $155 | $10 |
| Spironolactone | 14 | $106 | $8 |
| Lisinopril | 12 | $69 | $6 |
2013: 12 drugs
| Isosorbide Dinitrate | 26 | $3,149 | $121 |
| Metoprolol | 19 | $973 | $51 |
| Clopidogrel | 17 | $753 | $44 |
| Losartan | 24 | $539 | $22 |
| Atorvastatin | 14 | $534 | $38 |
| Furosemide | 71 | $397 | $6 |
| Pravastatin | 17 | $332 | $20 |
| Amlodipine Besylate | 34 | $285 | $8 |
| Carvedilol | 17 | $261 | $15 |
| Fosinopril | 16 | $239 | $15 |
| Metoprolol | 25 | $213 | $9 |
| Simvastatin | 18 | $190 | $11 |
Money from drug and device companies
$137 in 2025
| 2025 | 1 | 1 | None | $137 |
| 2019 | 1 | 1 | None | $82 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| BridgeBio Pharma | Attruby | $137 | 1 payment
|
See the published payment
| BridgeBio Pharma | Meals · 2025-12-09 | Attruby | $137 |
See earlier years (2019)
2019: $82
| Regeneron Pharmaceuticals | Eylea | $82 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 80.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1427184811
- Licence
- MA L-224611
- Trained
- Harvard Medical School, 2005 · 21 years ago
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 751 S Bascom Ave, Valley Specialty Center, San Jose, CA, 95128
- NPI first listed
- 2007-02-27
- NPI last updated
- 2012-11-06
This is when the NPI record was last certified, not a medical board exam.